Now in its 6th year, the Christine Pierre Clinical Trials Lifetime Achievement Award, in association with mdgroup, celebrates the ground-breaking work and contributions of individuals across the field of clinical trials who are making a positive difference. The shortlist for the 2020 prize has been announced and we are taking a closer look at each of the nominees - see all the profiles here. Here we focus on Dr Paul Glimcher, Professor at NYU Grossman School of Medicine and Chief Scientific Officer at Datacubed Health. Cast your vote here to have your say on this years winner.
Why he was nominated
"I am nominating Dr. Paul Glimcher for his outstanding contributions to clinical research in the areas of neuroscience and neuroeconomics. Paul has spent a lifetime working to understand the brain, and the science of human decision making. This includes significant contributions, such as the first quantitative test of the Dopamine Reward Prediction Error Signal, which showed the computation of reward prediction at the neurological level.
During his career, Dr. Glimcher has published nearly 100 academic articles. His contributions to the field of neuroeconomics are particularly noteworthy. Dr. Glimcher is often cited as having published the first academic paper in neuroeconomics. He has written several books on the subject, including Decisions, Uncertainty and the Brain: The science of Neuroeconomics, which is considered a treatise on the field. As a result, it won a PROSE Award for Best Medical Science Book in 2003.
Dr. Glimcher is a fellow of the American Association for the Advancement of Science. He has done work as an investigator for the National Eye Institute, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, and the National Institute on Aging. He is also a Julius Silver Professor of Neural Science at NYU Grossman School of Medicine and leads the Neuroeconomics Lab, part of the Institute for the Study of Decision Making.
But his contributions far exceed the academic realm. In 2016 he launched Datacubed Health with the mission of creating better science and healthier communities by accelerating the pace of clinical research. Using concepts from neuroeconomics and behavioral science, Paul has developed a systematic approach to addressing two of the biggest challenges facing late stage clinical trials today: patient compliance and retention. His work in this area has demonstrated that by applying neuroeconomic strategies, compliance and retention rates can exceed 90% in longitudinal studies.
These strategies are already being used in major pharmaceutical studies today, including in the areas of ophthalmology, gastroenterology, neurology, and infectious diseases. Dr. Glimcher envisions a future where clinical trial patients are able to easily fit study participation into their everyday life. For these reasons, I nominate him for the Christine Pierre Clinical Trials Lifetime Achievement Award.”
How the voting works
Voting is now open until 9 October 2020, 12pm GMT. We will impartially encourage our online community to vote; each finalist is also encouraged to reach out to their colleagues and contacts. Anyone in the online clinical trials community can vote, but only once each. Both voting and the opinion of the expert panel will be taken into account when choosing the winner. The prize will be presented at the Clinical Trials Europe virtual event on 4 November. Cast your vote for this year's Lifetime Achievement Award winner here.